Nolatrexed Uses, Dosage, Side Effects and more
Nolatrexed is under investigation in clinical trial NCT00012324 (Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Nolatrexed |
| Generic | Nolatrexed |
| Nolatrexed Other Names | Nolatrexed |
| Type | |
| Formula | C14H12N4OS |
| Weight | Average: 284.34 Monoisotopic: 284.073182196 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
